Literature DB >> 15607400

Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction.

Rodica Pop-Busui1, Ian Kirkwood, Helena Schmid, Victor Marinescu, Justin Schroeder, Dennis Larkin, Elina Yamada, David M Raffel, Martin J Stevens.   

Abstract

OBJECTIVES: This study was designed to explore the relationships of early diabetic microangiopathy to alterations of cardiac sympathetic tone and myocardial blood flow (MBF) regulation in subjects with stable type 1 diabetes.
BACKGROUND: In diabetes, augmented cardiac sympathetic tone and abnormal MBF regulation may predispose to myocardial injury and enhanced cardiac risk.
METHODS: Subject groups comprised healthy controls (C) (n = 10), healthy diabetic subjects (DC) (n = 12), and diabetic subjects with very early diabetic microangiopathy (DMA+) (n = 16). [(11)C]meta-hydroxyephedrine ([(11)C]HED) and positron emission tomography (PET) were used to explore left ventricular (LV) sympathetic integrity and [(13)N]ammonia-PET to assess MBF regulation in response to cold pressor testing (CPT) and adenosine infusion.
RESULTS: Deficits of LV [(11)C]HED retention were extensive and global in the DMA+ subjects (36 +/- 31% vs. 1 +/- 1% in DC subjects; p < 0.01) despite preserved autonomic reflex tests. On CPT, plasma norepinephrine excursions were two-fold greater than in C and DC subjects (p < 0.05), and basal LV blood flow decreased (-12%, p < 0.05) in DMA+ but not in C or DC subjects (+45% and +51%, respectively). On adenosine infusion, compared with C subjects, MBF reserve decreased by approximately 45% (p < 0.05) in DMA+ subjects. Diastolic dysfunction was detected by two-dimensional echocardiography in 5 of 8 and 0 of 8 consecutively tested DMA+ and DC subjects, respectively.
CONCLUSIONS: Augmented cardiac sympathetic tone and responsiveness and impaired myocardial perfusion may contribute to myocardial injury in diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15607400     DOI: 10.1016/j.jacc.2004.09.033

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  54 in total

Review 1.  What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes.

Authors:  Rodica Pop-Busui
Journal:  J Cardiovasc Transl Res       Date:  2012-05-30       Impact factor: 4.132

2.  Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes.

Authors:  T H Schindler; A D Facta; J O Prior; J Cadenas; W A Hsueh; M J Quinones; H R Schelbert
Journal:  Heart       Date:  2006-08-29       Impact factor: 5.994

Review 3.  Role of PET in the evaluation and understanding of coronary physiology.

Authors:  Thomas H Schindler; Xiao-Li Zhang; Gabriella Vincenti; Leila Mhiri; René Lerch; Heinrich R Schelbert
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

4.  I-123 metaiodobenzylguanidine imaging in non-insulin-dependent diabetic patients with normal myocardial perfusion scans: new insights into their increased cardiac morbidity and mortality rates.

Authors:  Nauman Mushtaq; Myron C Gerson
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

Review 5.  Assessment of coronary endothelial function using PET.

Authors:  Keiichiro Yoshinaga; Osamu Manabe; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2011-05       Impact factor: 5.952

Review 6.  Neurologic complications of diabetes.

Authors:  Gerald A Charnogursky; Nicholas V Emanuele; Mary Ann Emanuele
Journal:  Curr Neurol Neurosci Rep       Date:  2014-07       Impact factor: 5.081

Review 7.  Cardiac sympathetic neuronal imaging using PET.

Authors:  Riikka Lautamäki; Dnyanesh Tipre; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

8.  Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts.

Authors:  Nina Kaludercic; Andrea Carpi; Takahiro Nagayama; Vidhya Sivakumaran; Guangshuo Zhu; Edwin W Lai; Djahida Bedja; Agnese De Mario; Kevin Chen; Kathleen L Gabrielson; Merry L Lindsey; Karel Pacak; Eiki Takimoto; Jean C Shih; David A Kass; Fabio Di Lisa; Nazareno Paolocci
Journal:  Antioxid Redox Signal       Date:  2013-05-22       Impact factor: 8.401

9.  Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes.

Authors:  Cecilia Marini; GianPaolo Bezante; Patrizia Gandolfo; Elisa Modonesi; Silvia D Morbelli; Angelo Depascale; Daniela Rollando; Davide Maggi; Manuela Albertelli; Riccardo Armonino; Manrico Balbi; Claudio Brunelli; Renzo Cordera; Gianmario Sambuceti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-03       Impact factor: 9.236

10.  Increased left ventricular torsion in uncomplicated type 1 diabetic patients: the role of coronary microvascular function.

Authors:  Ganesh Nallur Shivu; Khalid Abozguia; Thanh Trung Phan; Ibrar Ahmed; Rebekah Weaver; Parth Narendran; Martin Stevens; Michael Frenneaux
Journal:  Diabetes Care       Date:  2009-06-09       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.